Rosiglitazone and Liver Failure

  1. William L. Isley, MD; and
  2. Julie C. Oki, PharmD
  1. University of Missouri; Kansas City, MO 64111 (Isley, Oki)

    The Editors welcome submissions for possible publication in the Letters section. Authors of letters should:

    •Include no more than 300 words of text, three authors, and five references

    •Type with double-spacing

    •Send three copies of the letter, an authors' form signed by all authors, and a cover letter describing any conflicts of interest related to the contents of the letter.

    Letters commenting on an Annals article will be considered if they are received within 6 weeks of the time the article was published. Only some of the letters received can be published. Published letters are edited and may be shortened; tables and figures are included only …

    « Previous | Next Article »Table of Contents